|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Hypertriglyceridemia during treatment with estrogen and oral contraceptives. |
| Gershberg H; Hulse M; Javier Z |
| Obstetrics and Gynecology 31(2): 186-189. February 1968. |
| Impaired glucose tolerance in 49 women taking Envoid (5 mg norethynodrel, .075 mg mestranol) is reported and |
| evidence that mestranol is the disposing factor is presented. 23 of 38 (61%) women who had taken the drug for more |
| than 10 months had triglyceride levels greater than 110 mg/100 ml. Generally, triglyceride levels increased with the |
| duration of treatment. However, cholesterol levels were not markedly increased. Administration of mestranol alone |
| resulted in a prompt increase in plasma triglyceride levels. Except for 1 woman who had been under long-term |
| Enovid treatment, triglyceride levels returned to normal soon after discontinuation of treatment. The results suggest |
| that hypertriglyceridemia resulting from oral contraceptives containing estrogens is due to an alteration in liver |
| function. (PubHealth.info Document ID: CONT9T 1087-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Hypertriglyceridemia during treatment with estrogen and |
| oral contraceptives.", is(are) Gershberg H; Hulse M; Javier Z. The source of this article is "Obstetrics and |
| Gynecology 31(2): 186-189. February 1968.". This article was published in 1968 in English language(s). |
| (PubHealth.info® Document ID: CONT9T 1087-06. All rights reserved with PubHealth.info) PIN: 41087 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |